A Study of ANAVEX3-71 in Adults With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
A study to evaluate the safety, tolerability, efficacy, pharmacokinetics, and electrophysiology of ANAVEX3-71 in patients with Schizophrenia.
Epistemonikos ID: 9c2266d8b368098fdc7b4c133027d340d847bf5d
First added on: May 15, 2024